BSE filing, NSE: CEMPRO. Summary written from the filing by ALFA Finder's alert engine.
Cemindia Projects Ltd: key numbers
- Share price
- ₹1,230.20
- Market cap
- ₹22,688 Cr
- Revenue (annual)
- ₹10,061 Cr
- Net profit (annual)
- ₹597.7 Cr
- P/E (TTM)
- 37.7×Sector 31.3×
- Promoter holding
- 62.84%-4.62% QoQ
- FII holding
- 6.23%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cemindia Projects Ltd
All →Cemindia Projects Board Meeting Date
Cemindia Projects has scheduled its Board of Directors meeting for 05 Nov 2026 to approve Q1/H1 FY27 umaudited results. No financial figures are disclosed in this advance intimation.
Cemindia Projects Capital Structure Change
Motilal Oswal Mutual Fund schemes acquired 58.66 lakh Cemindia Projects shares through QIP and open market. Non-promoter SAST Reg 29 disclosure reports stake rising to 5.16%.
Cemindia Projects Other Announcement
Cemindia Projects filed its quarterly shareholding pattern as of 19 Oct 2026. Promoter group holds 62.84%, and the promoter's name suffix change is pending in PAN records.
Cemindia Projects Fund Raise of ₹1,400 Cr
Cemindia Projects' board approved a ₹1,400 Crore QIP of 12,635,379 equity shares. Shareholder approval via AGM/EGM is scheduled for 17 August 2026.
- Value
- ₹1,400 Cr
Cemindia Projects Capital Structure Change
Cemindia Projects Ltd approved the closure of its QIP and allocated 1.26 crore shares at ₹1,108 per share, raising approximately ₹1,400 crore.
- Value
- ₹1,400 Cr
Cemindia Projects Credit Rating
Cemindia Projects Limited received new credit ratings from Crisil Ratings Limited, assigning 'Crisil AA/Stable' for long-term and 'Crisil A1+' for short-term bank loan facilities.
Other board meeting date announcements
All →Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.